iZafe Group (IZAFE-B) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
16 Feb, 2026Executive summary
Achieved annual recurring revenue (ARR) target, growing from SEK 1.7 million to SEK 10 million entering 2026, with over 1,000 active units and strong municipal demand.
Transitioned to a fully recurring revenue model, with Q4 net sales of 2,435 TSEK, all from license revenues, and no hardware sales compared to the prior year.
Expanded Nordic presence with new distribution agreements in Iceland and Norway, and consolidated Dutch operations.
Launched new modular external display and remote care system for Dosell after the quarter, enhancing product flexibility.
Financial highlights
Hardware sales provide revenue but low or negative margins, serving as an enabler for high-margin recurring license income (90-95% margin).
Q4 net sales: 2,435 TSEK, entirely from recurring license revenues; Q4 EBIT: -5,714 TSEK; Q4 EBITDA: -3,888 TSEK.
Q4 net result: -4,857 TSEK; EPS: -0.01 SEK; full-year net sales: 5,991 TSEK; full-year net result: -16,839 TSEK.
Cash and cash equivalents at year-end: 1,673 TSEK.
Acquisition of distributor at year-end shifts hardware sales internally, increasing recurring license revenue on markets where direct sales occur.
Outlook and guidance
Entering 2026 with ARR of 10 MSEK and a stable, growing base, with growth expected in both the number of municipalities and units per municipality.
Forecasts are based on current growth rates, independent of potential Adda contract wins.
Expansion plans include hiring in the Netherlands and Sweden to support scaling and customer implementation.
Focus for 2026 on expanding customer base and increasing penetration among existing customers.
Latest events from iZafe Group
- Recurring revenue model established, ARR quadrupled, and European expansion accelerates.IZAFE-B
Q3 20253 Nov 2025 - Recurring revenue growth and European expansion drive strong momentum in Q2 2025.IZAFE-B
Q2 202529 Aug 2025 - Revenue surged as Dosell expanded, with losses narrowing and growth momentum accelerating.IZAFE-B
Q3 202413 Jun 2025 - Net sales fell in Q2, but demand and new contracts signal growth ahead.IZAFE-B
Q2 202413 Jun 2025 - Recurring revenues and international expansion drive improved results and future growth.IZAFE-B
Q1 20256 Jun 2025 - Revenue doubled and ARR surged as iZafe accelerates international expansion.IZAFE-B
Q4 20245 Jun 2025